Effect of SR 27417, a novel PAF antagonist on antigen-induced hypotension in the rat

Journal of Lipid Mediators and Cell Signalling

Volumn 15, Issue 2, 1997, Pages 115-123

  Herbert, Jean Marc ^a   Bernat, André ^a   Tibiriça, Eduardo ^b  

^a SANOFI   (France)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

antigen; hypotension; platelet activating factor (PAF); SR 27417

Indexed keywords

ANTIGEN; FOROPAFANT; OVALBUMIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANAPHYLACTIC SHOCK; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG INHIBITION; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RAT; SENSITIZATION;

ANIMALS; ANTIGENS; HYPOTENSION; MALE; OVALBUMIN; PLATELET ACTIVATING FACTOR; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLES;

EID: 0031047017     PISSN: 09297855     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-7855(96)00452-X     Document Type: Article

References (16)

1. Bernat, A., Herbert, J.M., Salel, V., Lespy, L. and Maffrand, J.P. (1992) Protective effect of SR 27417, a novel PAF antagonist, on PAF-or endotoxin-induced hypotension in the rat and the guinea-pig. J. Lipid Mediators 51, 41-48.
2. Braquet, P., Mencia-Huerta, J.M., Chabriet, P.E., Touqui, L. and Vargaftig, B.B. (1987a) The promise of platelet activating factor. ISI Atlas of Science, 1, 187-198.
3. Braquet, P., Shen, T.Y., Touqui, L. and Vargaftig, B.B. (1987b) Perspectives in platelet activating factor research. Pharmacol. Rev., 39, 97-145.
4. Camussi, G., Tefta, C. and Bussolino, F. (1983) Inhibitory effect of prostacyclin (PGI2) on neutropenia induced by intravenous injection of platelet activating factor (PAF) in rabbit. Prostaglandins 25, 343-351.
5. Casals-Stenzel, J. (1987) Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis. Immunopharmacology, 13, 117-124.
6. Casals-Stenzel, J., Muacevic, G. and Weber, K.H. (1987) Pharmacological actions of WEB-2086, a new specific antagonist of platelet activating factor. J.Pharmacol. Exp. Ther., 241, 974-981.
7. Chang, S.W., Feddersen, CO., Henson, P.M. and Voelker, N.F. (1987) Platelet activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J. Clin. Invest. 79, 1498-1509.
8. Chan-Yeung, M., Lam, S., Chan, H., Tse, K.S. and Salari, H. (1991) The release of platelet-activating factor into plasma during allergen-induced bronchoconstriction. J. Allergy Clin. Immunol. 87, 667-673.
9. Damas, J. (1989) Involvement of PAF-acether in the anaphylactic shock in the rat. J. Lipid Mediators, 1, 161-170.
10. Handley, D.A. (1988) Development and therapeutic indications for PAF receptor antagonists. Drugs of the Future, 13, 137-152.
11. Herbert, J.M., Bernat, A., Valette, G. et al. (1991a) Biochemical and pharmacological activities of SR 27417, a highly potent, long acting PAF receptor antagonist. J. Pharmacol. Exp. Ther., 259, 44-51.
12. Herbert, J.M., Lespy, L. and Maffrand, J.P. (1991b) Protective effect of SR 27417, a novel PAF antagonist, on lethal anaphylactic and endotoxin-induced shocks in mice. Eur. J. Pharmacol., 205, 271-276.
13. McManus, L.M., Hanahan, D.J., Demopoulos, C.A. and Pinckard, R.N. (1980) Pathobiology of the intravenous infusion of acethyl-glyceryl ester phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit. J. Immunol. 124, 2919-2924.
14. Terashita, Z., Imura, Y., Nishikawa, K. and Sumida, S. (1985) Is platelet activating factor (PAF) a mediator of endotoxin shock? Eur. J. Pharmacol., 109, 257-261.
15. Terashita, Z.I., Imura, Y., Shino, A. and Nishikawa, K. (1987) A lethal role of platelet activating factor in anaphylactic shock in mice. JPET, 243(1), 378-383.
16. Terashita, Z.I., Kawamura, M., Takatani, M., Tsushima, S., Imura, Y. and Nishikawa, K. (1992) Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents. JPET, 260(2), 748-755.